Skip to content
ReoStem
The future of allogenic stem cells
ReoStem
  • HOME
  • ABOUT US
  • TECHNOLOGY
  • PUBLICATIONS
  • PATENTS
  • CONTACT US
  • HOME
  • ABOUT US
  • TECHNOLOGY
  • PUBLICATIONS
  • PATENTS
  • CONTACT US

Monthly Archives: January 2015

You are here:
  1. Home
  2. 2015
  3. January

Human Embryonic Stem Cells in the Treatment of Spinocerebellar Ataxia, Journal of Clinical Case Reports

Publications, Scientific PublicationsBy adminJanuary 30, 2015Leave a comment

Spinocerebellar ataxias, dominantly inherited ataxias, constitute a large heterogenous group of progressive neurodegenerative disorders that commonly affects the cerebellum and its afferent and efferent pathways.

Safety and Efficacy of Human Embryonic Stem Cells for the Treatment of Cerebrovascular Accident: A Case Series

Publications, Scientific PublicationsBy adminJanuary 1, 2015Leave a comment

To evaluate the efficacy and safety of hESC therapy on 22 patients with CVA.

Nutech Functional Score: A New Functional Scoring System for Patients With Cerebrovascular Accidents

Publications, Scientific PublicationsBy adminJanuary 1, 2015Leave a comment

Stroke or cerebrovascular accident happens when a part of the brain gets poor supply of blood that leads to either hemorrhage or blockage due to deoxygenation

Human embryonic stem cell for the treatment of multiple sclerosis: A case report

Publications, Scientific PublicationsBy adminJanuary 1, 2015Leave a comment

Multiple sclerosis (MS) is a chronic demyelinating disease with inflammatory neurodegeneration. It is caused by the genesis of an autoimmune response to self-antigens in a genetically susceptible individual.

Nutech Functional Score (NFS), a New Scoring System to Assess the Level of Impairment in Patients with Cerebral Palsy

Publications, Scientific PublicationsBy adminJanuary 1, 2015Leave a comment

A non-progressive disorder cerebral palsy (CP) occurs as a result of the damage to the brain of a fetus and newborns

Copyright @ 2018 ReoStem
Go to Top

Thanks for contacting ReoStem! We have received your response and we will get back to you shortly.